Serial 88904727
Live / Registered — Registered (as of 17 Sept 2024)
What this means for you
Registered since 17 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88904727
- Registration number
- 7507876
- Mark type
- Design / logo
- Filed
- 07 May 2020
- Published for opposition
- 05 Oct 2021
- Registered
- 17 Sept 2024
- Attorney of record
- Stephanie H. Bald
Goods and services
- Class 005 — Pharmaceuticals: House mark for a full line of pharmaceuticals; pharmaceuticals for human use, namely, pharmaceuticals for treatment and prevention of pain and allergic, inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions mediated via intracellular transport processes
- Class 042 — Scientific and technological services: Pharmaceutical research and development services
Owner
- Entrada Therapeutics, Inc., Boston, MA, US
- Entrada Therapeutics, Inc., Boston, MA, US
- Entrada Therapeutics, Inc., Boston, MA, US
Prosecution history
- 17 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 13 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Jul 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 29 May 2024 — USE AMENDMENT FILED
- 29 May 2024 — USE AMENDMENT FILED
- 29 May 2024 — USE AMENDMENT FILED
- 07 Jul 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 29 May 2024 — SOU EXTENSION 5 GRANTED
- 29 May 2024 — SOU EXTENSION 5 FILED
- 29 May 2024 — SOU TEAS EXTENSION RECEIVED
- 09 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED